在随机对照试验中测量健康干预措施对环境的影响 - - 范围审查
Beatriz Goulão1, Dwayne Boyers2, Oscar Forbes1
1Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK.
Journal of clinical epidemiology
|March 7, 2025
概括
环境结果越来越多地被纳入临床试验,以评估干预措施.
科学领域:
- 环境科学环境科学
- 临床研究是临床研究.
- 卫生系统研究 卫生系统研究
背景情况:
- 医疗保健对全球温室气体排放作出了重大贡献.
- 减少碳排放是卫生系统的战略优先事项.
- 将环境数据纳入健康决策是必不可少的.
研究的目的:
- 进行临床试验中环境结果的范围审查.
- 评估环境结果在试验设计,分析和解释中的收集,方法和影响.
- 了解临床决策中考虑环境结果的程度.
主要方法:
- 搜索了Embase,MEDLINE和Cochrane图书馆,找到符合条件的随机对照试验 (RCT) 和协议.
- 包括收集或计划收集环境结果的研究.
- 提取数据并分析定量和定性信息.
主要成果:
- 包括16个RCT或协议,最近的出版物显著增加.
- 环境结果主要用于确认干预措施的排放减少.
- 大多数试验使用生命周期评估或碳足迹数据;分析往往没有预先指定.
- 环境和临床结果普遍一致;患者和公众的参与是最小的.
结论:
- 环境结果在RCT中越来越多地被纳入其中,但它们在临床决策中的作用仍然不确定.
- 试验者和环境专家之间的合作对于适当的设计和分析至关重要.
- 患者,公众和卫生专业人员的参与是决策中接受环境结果的关键.
更多相关视频
05:59Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
6.7K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
What is an Experiment?
10.2K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
10.2K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Hazard Ratio
73
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
73
